10.01.2024 02:05:05
|
P3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock Up
(RTTNews) - P3 Health Partners Inc. (PIII) reaffirmed guidance for 2023 and announced guidance for 2024.
Looking ahead for fiscal year 2023, the company still expects revenue to be in the range of $1.2 billion to $1.25 billion, and Medicare Advantage Members of 115,000 to 120,000. Analysts polled by Thomson Reuters expect the company to report revenues of $1.22 billion for fiscal year 2023. Analysts' estimates typically exclude special items.
For full-year 2024, the company projects revenue to be between $1.45 billion and $1.55 billion. Analysts expect revenue of $1.41 billion for full-year 2024. Medicare Advantage Members are expected to be in the range of 125,000 to 135,000.
PIII closed Tuesday's regular trading at $1.35 up $0.01 or 0.75%. In the after-hours trading, the stock further gained $0.17 or 12.59%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu P3 Health Partners Inc Registered Shs -A-mehr Nachrichten
11.11.24 |
Ausblick: P3 Health Partners A öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu P3 Health Partners Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
P3 Health Partners Inc Registered Shs -A- | 0,23 | -3,77% |
|
Letzte Top-Ranking Nachrichten
Börse aktuell - Live Ticker
Mehrheitlich freundliche Börsen in AsienIn Fernost dominieren die Bullen.